We have today, on what would have been Doddie's 54th birthday, announced we will invest more than £500,000 in clinical trials to help speed up the search for effective treatments, and one day a cure, for MND.

The funding will be allocated through our Clinical Research Infrastructure Awards, and is part of the our Catalysing a Cure research strategy which launched last year, The awards will support multiple centres across the UK to deliver MND trials by funding the time of clinical staff. 

When Doddie was first diagnosed in 2016 and subsequently set up My Name'5 Doddie Foundation, there was a severe lack of clinical trials in the UK. To date, we have already invested more than £3 million in UK trial centres to help them recruit the staff they need to deliver MND clinical trials – including support for the delivery of MND-SMART and TRICALS studies. We have also provided funding to enable MND trial delivery in Newcastle, leading to further recruitment to several national and local clinical trials.

Dr Tim Williams, consultant neurologist at the Newcastle Hospitals NHS Foundation Trust, said: “The support we have received in Newcastle has been absolutely fundamental to a sea change in MND trial conduct and activity in Newcastle. It's been a great thing and I only hope such support continues and might reasonably be rolled out elsewhere. I think this is a highly effective and tangible use of funds.”

Jessica Lee, our Director of Research, said: “When Doddie was diagnosed in 2016, there were few MND clinical trials running in the UK. Since then, there has been significant progress and an increased investment into UK MND trials. It means today, the landscape is very different with there are many clinical trials running nationwide. 

“However, despite the increasing number of trials, not all centres are currently able to deliver them at pace due to a lack of specialised staff with dedicated time to spend on MND projects.

“Doddie was passionate about the need for more MND clinical trials, to give newly diagnosed people hope and purpose, and to accelerate the search for effective treatments. This commitment of an additional £500,000 to support individual trial centres, will enable them to buy-out the time of specialised staff to work on MND clinical trials, and make a real difference in our ongoing mission to end MND.” 

Our announcement arrives as the public prepares to pull on their favourite tartan in memory of Doddie on what would have been his birthday. Doddie's wife Kathy and two of his sons, Ben and Hamish, helped launch the initiative on social media this week. 

There are no rules on what tartan to wear, although we encourage you to sport Doddie's famous yellow and blue colours on the day, if you can!

We have so far committed more than £11m to MND research, with a further £2m invested in supporting people living with MND. 

The last 12 months have signalled a significant year of fundraising, with a further £6m committed to research by the end of 2024. 

Today would’ve been Doddie’s 54th birthday, and there seems no more appropriate way to honour him than with a sea of tartan. We urge as many people as possible to join us today and beyond to raise awareness of MND, and remind us of the relentless need to pursue Doddie’s legacy, a world free of MND.

Paul Thompson

Our Director of Fundraising

Prizes will be available for the best tartan snaps, with a bottle of Doddie’5 Moonshine or Cap Classique sparkling wine, Doddie merch and a rugby ball up for grabs as part of the competition.

To enter the competition, please upload your image and use the hashtag #myname5doddie. Alternatively, post your pictures as comments on our Facebook and X (formerly Twitter) posts.

More news & stories

View all
 picture
Fundraising MND stories
13 Oct 2026

Kathy dedicates Women of the Year honour to the MND community

Kathy Weir's dedication to people affected by motor neuron disease (MND) has been recognised with the Campaigning Champions Award at the 72nd Women of the Year Lunch…
Read more
 picture
Research
13 Oct 2026

Multimillion-pound partnership breaks down barriers in MND research

Motor neuron disease (MND) is one of the most complex challenges in medical research. While excellent work is taking place across the globe, no single researcher…
Read more
 picture
Research
12 Oct 2026

EXPERTS-ALS rules out Ropinirole as a potential treatment for MND

The latest results from the EXPERTS-ALS clinical trial have shown that Ropinirole is unlikely to be an effective treatment for motor neuron disease (MND), and the…
Read more
Bell icon

Join our Newsletter!

By subscribing, you confirm that you agree with our terms and conditions.